Hunter: Chicago Public Schools to receive $25 million in evidence-based funding

CHICAGO — State Senator Mattie Hunter announced that Chicago Public Schools will receive over $25 million in additional funding to help address the financial challenges of recent years.

“Our students deserve the best education with access to quality materials and support,” said Hunter (D-Chicago). “This investment is a step forward in creating equitable learning environments where every child in Chicago and throughout the state can succeed.”

The funding comes from the 2017 Illinois Senate Democrat-backed evidence-based funding formula — an overhaul of the way the state funds K-12 education. The law made school funding more equitable by calculating the needs of individual school districts and basing its state revenue on those needs. The formula takes into account a district’s total enrollment, poverty rate and number of special education or English language learners, among other factors.

Chicago Public School District 299 is set to receive $25,800,109 through the formula. The Fiscal Year 2025 budget invested $350 million in new funding into students’ success through the evidence-based funding model.

For more information on the FY 25 evidence-based funding distribution, visit the Illinois State Board of Education’s website.

Hunter applauds Medicare drug price cuts

CHICAGO — A longtime leader in advancing affordable health care, State Senator Mattie Hunter applauded the Biden Administration’s announcement Thursday that a deal has been reached between Medicare and pharmaceutical companies to lower the prices for 10 costly and commonly prescribed medications.

“We’ve watched the cost of living skyrocket, and people simply cannot afford the essentials anymore,” said Hunter (D-Chicago). “This legislative session, I passed a law limiting the cost of asthma inhalers — building on years of work in Illinois to make prescription medication accessible and affordable to those who need it. I am thrilled to see our federal government act with similar priorities.”

The deal will lower the price of drugs used by millions of older adults to help manage diabetes, blood cancers and arthritis, as well as prevent heart failure, strokes and blood clots. Medicare beneficiaries are expected to save $6 billion on the new prices, which will take effect in 2026.

Read more …

Hunter expands task force for missing and murdered women

SPRINGFIELD — A dedicated advocate for victims and their families, State Senator Mattie Hunter passed a law to expand the Task Force for Missing and Murdered Chicago Women, adding two seats for Chicago police officers.

“Through the work of the task force and dedicated individuals who are shining a light on this crisis, we are beginning to see the true scale of this issue and areas for improvement related to managing cases and data,” said Hunter (D-Chicago). “It’s vital we bring in representatives from the Chicago Police Department to speak to current practices and how we can best move forward.”

Despite making up only 2% of Chicago’s population, Black women and girls account for about 30% of the city’s missing persons cases — an alarming disparity that remains the focus of the Task Force for Missing and Murdered Chicago Women. The task force, established through legislation Hunter passed in 2022, is studying methods for tracking and collecting data on violence against Chicago women and working to develop strategies to reduce violence and prevent future tragedies. The task force meets monthly and is due to submit its first report to the General Assembly by Dec. 31.

Read more …

Hunter law cuts cost of asthma inhalers

SPRINGFIELD — Individuals with asthma will soon see significant savings on their prescription inhalers thanks to a new law from State Senator Mattie Hunter.

“As someone with asthma, I know the importance of having access to an inhaler — and the cost that comes with it,” said Hunter (D-Chicago). “People shouldn’t be faced with financial hardship when it comes to essential medication.”

Under the new law, health insurance providers cannot deny or limit coverage for prescription inhalers, and insured individuals will pay no more than $25 for a 30-day supply of their inhaler.

Read more …